Salt Subs in Normal BP; Stroke Thrombectomy Without $$; Walmart's CVD Blood Test Recent developments of interest in cardiovascular medicine Feb 13, 2024
FDA Reviewers Skeptical on TriClip for Tricuspid Regurgitation Tricuspid valve repair system is up for advisory committee scrutiny on Tuesday Feb 12, 2024
Before Stroke Thrombectomy, Keep the Bed Flat, Trial Says Tilting the head of the bed up during early window in large vessel occlusion hurts outcomes Feb 07, 2024
Bariatric Surgery & BP Control; PFA Vasospasm Aftermath; Texas Cardiologist Arrested Recent developments of interest in cardiovascular medicine Feb 06, 2024
Cardiology Ups Diversity; Universal CVD Risk Predictor; 93-Year-Old Cardiologist Recent developments of interest in cardiovascular medicine Jan 30, 2024
Drug-Related Endocarditis: A First Stab at Recommendations for Surgeons STS consensus statement on ethics, surgical criteria, transcatheter debulking Jan 30, 2024
Caution Raised for Post-TAVR Cardiac Surgeries Surgeons report rise in TAVR explants and other risky procedures Jan 29, 2024
FFR-Guided PCI Saves $$ Clamping Down on Unnecessary Stents in MI Patients Cost-effectiveness shown over angiographic guidance for complete revascularization Jan 26, 2024
AI Tool Predicts PCI Outcomes; Shellfish Blood Clotter; Persuasive CAC Scan Images Recent developments of interest in cardiovascular medicine Jan 23, 2024
'Tootsie Roll' Introduced for Leaky Transcatheter Heart Valves Covered stent and plug deployment to address complex paravalvular leaks Jan 18, 2024
Medical Cannabis-Arrhythmia Link; Watch Out for Lipoprotein(a); New SAVR Alternative Recent developments of interest in cardiovascular medicine Jan 16, 2024
Erectile Dysfunction Drugs Plus Nitrates Still a Losing Combination, Study Shows Cardioprotective effect of PDE5 inhibitors did not pan out with anti-anginals in the picture Jan 16, 2024
BP Tracking Undergarment; COPD Exacerbations & HF Events; Hemolysis After PFA Recent developments of interest in cardiovascular medicine Jan 09, 2024
HCM Drug Hopeful; Pre-Cardiac Cath Fasting in Doubt; Way to Visualize LAAO Issues? Recent developments of interest in cardiovascular medicine Jan 02, 2024
Nuclear Tracer Shortage; Weighing Post-Ablation OAC; Fix for Biased AI Tools? Recent developments of interest in cardiovascular medicine Dec 26, 2023
Colchicine Not the Answer for Recurring Arrhythmias After Ablation Anti-inflammatory effects did not translate to arrhythmia prevention in small trial Dec 21, 2023
HeartMate 3 Safety Concerns; First Cath Lab Standards for Kids; Single-Shot PFA Recent developments of interest in cardiovascular medicine Dec 19, 2023
Experts, Lawmakers Explore Downside of Drug-Price Negotiation Stifled innovation, reduced access suggested as future challenges Dec 14, 2023
Statins and CKD; Farxiga's Limited Symptom Improvement; Stop Wasted TNKase Recent developments of interest in cardiovascular medicine Dec 12, 2023
Win for Vegan Diet; Injectable Balloon Catheters OK'd; OAC Options After Failed DOAC Recent developments of interest in cardiovascular medicine Dec 05, 2023
Pulsed Field Ablation Eyed Cautiously for Coronary Spasms More evidence of PFA-provoked spasms, albeit without clinical manifestations Nov 29, 2023
Tomato-Blood Pressure Link; Afib and Neuroticism; Nerve Stimulation for POTS Recent developments of interest in cardiovascular medicine Nov 27, 2023
OCEANIC-AF Trial Sunk; Second Renal Denervation Device Approved; Strep-Stroke Link? Recent developments of interest in cardiovascular medicine Nov 21, 2023
Silent Gastrointestinal Bleeds Track With Antiplatelet Choice After PCI OPT-PEACE captured serial changes in gastrointestinal tract injury prior to overt bleeding Nov 17, 2023
Alleged Stroke Trial Misconduct; Ultrasound Tx for Severe AS; Farxiga's eGFR Drops Recent developments of interest in cardiovascular medicine Nov 15, 2023
Angioplasty Redeemed for Stable Angina in Sham-Controlled ORBITA-2 Reduced angina frequency with anti-anginal meds out of the picture Nov 11, 2023
Another Xenotransplant Death; Many Unaware of HF Diagnosis; Full-Body TAVR Protector Recent developments of interest in cardiovascular medicine Nov 07, 2023
Rampant Stent Overuse; Hot Tub Heart Risks Revisited; Cardiologist Runs for Office Recent developments of interest in cardiovascular medicine Oct 31, 2023
EP Study During TAVR Offers Better Prediction of Late Conduction Disturbances Interventional cardiologists trained to handle His bundle recordings at one center Oct 27, 2023
Tricuspid Valve Replacement Safe, Effective in Pivotal Trial Outcome data still awaited after positive interim results Oct 27, 2023
Mitral Valve TEER Device 'Horse Race' Draws Even Closer Additional patients in pivotal trial add to strength of the findings Oct 27, 2023
Small Aortic Annuli Not Inherently More Amenable to TAVR TAVR, SAVR result in similar outcomes in female-dominated VIVA randomized trial Oct 26, 2023
Tricuspid Clip Might Work for More Patients Than Thought Study shows better-than-expected benefit for expanded criteria cohort Oct 26, 2023
Targeting Collaterals During Primary PCI Disappoints in Trial Pressure-controlled intermittent coronary sinus occlusion appears safe in acute MI, though Oct 26, 2023
Even Less Aspirin With Ticagrelor-Based DAPT Safe After Stenting for ACS T-PASS trial weighs stopping aspirin within a month Oct 26, 2023
Drug-Coated Balloon Answers 'Embarrassing' Need for In-Stent Restenosis in U.S. Agent device avoids additional layer of stenting in patients with recurrent blockages Oct 25, 2023
Aortic Regurgitation Device Passes in Pivotal Trial JenaValve device hits benchmarks with improvement in pacemaker rates Oct 25, 2023
Combining TAVR, LAA Closure in Same Procedure Safe, Trial Says WATCH-TAVR suggests percutaneous approach can follow surgical pattern in not staging procedures Oct 25, 2023
Amulet vs Watchman Comparison Still Muddy Any Which Way LAA Leaks Are Defined The two devices continue to lead to similar clinical outcomes Oct 24, 2023
Low-Risk TAVR Converging or Diverging With Surgical Outcomes, Depending on the Valve Intermediate-term reports from PARTNER 3 and Evolut Low Risk trials Oct 24, 2023
